INSOMNIA is the #10 most commonly reported adverse reaction for PAROXETINE HYDROCHLORIDE, manufactured by Apotex Corp. There are 3,785 FDA adverse event reports linking PAROXETINE HYDROCHLORIDE to INSOMNIA. This represents approximately 2.0% of all 192,057 adverse event reports for this drug.
PAROXETINE HYDROCHLORIDE has an overall safety score of 78 out of 100. Patients taking PAROXETINE HYDROCHLORIDE who experience insomnia should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
Reporting Frequency
INSOMNIA3,785 of 192,057 reports
INSOMNIA is a less commonly reported adverse event for PAROXETINE HYDROCHLORIDE, but still significant enough to appear in the safety profile.
Other Side Effects of PAROXETINE HYDROCHLORIDE
In addition to insomnia, the following adverse reactions have been reported for PAROXETINE HYDROCHLORIDE:
INSOMNIA has been reported as an adverse event in 3,785 FDA reports for PAROXETINE HYDROCHLORIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.
How common is INSOMNIA with PAROXETINE HYDROCHLORIDE?
INSOMNIA accounts for approximately 2.0% of all adverse event reports for PAROXETINE HYDROCHLORIDE, making it a notable side effect.
What should I do if I experience INSOMNIA while taking PAROXETINE HYDROCHLORIDE?
If you experience insomnia while taking PAROXETINE HYDROCHLORIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.
Disclaimer: This analysis is based on FDA adverse event reports and is for informational purposes only. Reports do not prove causation. Always consult your healthcare provider.